Login / Signup

Mortality trends around the one-year survival mark after heart, liver, and lung transplantation in the United States.

Ashwin S NathanCatherine BlebeaPaula ChatterjeeArwin ThomassonJoshua M DiamondPeter W GroeneveldJay GiriHilary J GoldbergAndrew M Courtwright
Published in: Clinical transplantation (2020)
Although we did not find evidence that life-sustaining treatment is routinely continued until just beyond the one-year mark in heart and liver transplantation recipients, there was an unexpected increased risk of mortality in the 30 days following day 365 among lung transplant recipients.
Keyphrases
  • cardiovascular events
  • heart failure
  • risk factors
  • atrial fibrillation
  • extracorporeal membrane oxygenation
  • cardiovascular disease
  • kidney transplantation
  • combination therapy
  • replacement therapy